BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 10, 2006
View Archived Issues
Sustained anti-HCV activity seen with albumin interferon alfa-2b/ribavirin
Read More
GV-1001 may prolong survival in pancreatic cancer patients
Read More
Stable disease reported in phase I study of PHA-739358, patient recruitment continues
Read More
IKKbeta inhibition a potential means of treating rheumatoid arthritis
Read More
OROS-methylphenidate improves driving performance in teens with ADHD
Read More
Medarex and PacMab to develop antibody therapeutics for cancer
Read More
Ablynx and Wyeth collaborate to develop Nanobodies targeting TNF-alpha
Read More
4SC and University of Munster advance H5N1 program
Read More
Phase II study of Hemopure cleared to continue
Read More
Combretastatin A-4 imidazole analogues show potential for cancer therapy
Read More
Oxygent development update
Read More
Clearance for Schering AG to be integrated into the Bayer Group
Read More
Boehringer Ingelheim updates advanced pipeline, with focus on oncology
Read More
CGC-11047 studied in patients with AMD
Read More
OcuCure uses seed funding to advance compounds for AMD
Read More
DMD foundations fund research into membrane sealant
Read More
AzaSite Plus begins phase I safety study
Read More
Bioniche begins phase III trial of Urocidin for refractory bladder cancer
Read More
Cannasat Therapeutics signs contribution agreement for CAT-210
Read More
Provenge prolongs PSA doubling time in patients with early stage prostate cancer
Read More
Promising preclinical data for novel human mAb in IGF-1R-expressing tumors
Read More
Vertex reviews third quarter
Read More
Noxafil approved in E.U. for invasive fungal infections
Read More
Infuse Bone Graft recommended for approval in third indication
Read More
New anticancer agents patented
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Novel compounds with potential for treatment of gastrointestinal disorders reported
Read More
CBP-501: Preliminary phase I results and pharmacokinetic data
Read More
Phase I and pharmacokinetic data on CX-3543, a first-in-class rRNA biogenesis inhibitor
Read More